SCHEMBL3700238

SCHEMBL3700238

O=C1/C(=C\c2ccccc2)Cc2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 7/20 1.00
▸ MIF P14174 5/20 1.00
▸ MAOA P21397 4/20 1.00
▸ CYP19A1 P11511 2/20 0.76
▸ TNF P01375 2/20 0.76
▸ MAPT P10636 2/20 0.68
▸ ACHE P22303 3/20 0.67
▸ BCHE P06276 1/20 0.67
▸ PTGS2 P35354 2/20 0.66
▸ STK17B O94768 1/20 0.65
▸ KDM4E B2RXH2 1/20 0.60
▸ MEN1 O00255 1/20 0.60
▸ ALDH1A1 P00352 1/20 0.60
▸ KMT2A Q03164 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3694617 1.00 MAOB (1.00) MAOBMIFMAOACYP19A1TNF
SCHEMBL30462578 1.00 MAOB (1.00) MAOBMIFMAOACYP19A1TNF
SCHEMBL30462577 1.00 MAOB (1.00) MAOBMIFMAOACYP19A1TNF
SCHEMBL30977980 1.00 MAOB (1.00) MAOBMIFMAOACYP19A1TNF
SCHEMBL2981650 1.00 MAOB (1.00) MAOBMIFMAOACYP19A1TNF
SCHEMBL14033556 0.89 MIF (0.81) MAOBMIFMAOACYP19A1TNF
SCHEMBL27560521 0.88 MAOB (0.86) MAOBMIFMAOACYP19A1TNF
SCHEMBL6967940 0.86 MAOB (0.76) MAOBMIFMAOACYP19A1TNF
SCHEMBL7701204 0.86 MIF (1.00) MAOBMIFMAOACYP19A1TNF
SCHEMBL15489882 0.86 MAOB (0.76) MAOBMIFMAOACYP19A1TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166274-B2 Synergistically high SPF photoprotective UV-screening compositions comprising insoluble organic sunscreen particles/diarylbutadiene compounds L'OREAL (FR) 2007-01-23 — — US claimed
US-20040047820-A1 Synergistically high SPF photoprotective UV-screening compositions comprising insoluble organic sunscreen particles/diarylbutadiene compounds SOCIETE L'OREAL S.A. (FR) 2004-03-11 — — US claimed
US-6627180-B2 Particles having protection factor UV-APPD and an amino substituted 2-hydroxybenzophenone SOCIETE L'OREAL S.A. (FR) 2003-09-30 — — US claimed
US-20030152532-A1 SYNERGISTICALLY UV-PHOTOPROTECTING COMPOSITIONS COMPRISING MIXED SCREENING AGENTS SOCIETE L'OREAL S.A. (FR) 2003-08-14 — — US claimed
CN-107847414-B Composition comprising a UV screening agent, an anionically crosslinked hydrophilic polymer, a surfactant having an HLB less than or equal to 5, and a siloxane copolymer 欧莱雅 2021-09-10 — — CN disclosed
EP-2872107-B1 COSMETIC COMPOSITION CONTAINING SCREENING COMPOSITE PARTICLES OREAL (FR) 2021-07-21 — — EP disclosed
CN-111343968-A Composition comprising at least one acrylic polymer and at least one insoluble organic masking agent 莱雅公司 2020-06-26 — — CN disclosed
US-9682919-B2 Small molecule inhibitors of Dusp6 and uses therefor University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2017-06-20 — — US disclosed
US-20160355459-A1 Small Molecule Inhibitors of Dusp6 and Uses Therefor UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2016-12-08 — — US disclosed
US-9439877-B2 Small molecule inhibitors of Dusp6 and uses therefor University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2016-09-13 — — US disclosed
US-20160113889-A1 Small Molecule Inhibitors of Dusp6 and Uses Therefor UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2016-04-28 — — US disclosed
US-9127016-B2 Small molecule inhibitors of Dusp6 and uses therefor University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2015-09-08 — — US disclosed
WO-1999065495-A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB SMITHKLINE BEECHAM CORPORATION (US) 1999-12-23 — — WO disclosed
EP-0015156-A1 Basically-substituted tricyclic pyrazoles, their preparation and their use as antiinflammatory agents E.R. Squibb & Sons, Inc. (US) 1980-09-03 — — EP disclosed
US-4173634-A Basically-substituted tricyclic pyrazoles useful as antiinflammatory agents E. R. SQUIBB & SONS, INC. (US) 1979-11-06 — — US disclosed
US-4053514-A ANTIDEPRESSANTS E. R. SQUIBB & SONS, INC. (US) 1977-10-11 — — US disclosed
US-4038274-A ANTIDEPRESSANTS E. R. SQUIBB & SONS, INC. (US) 1977-07-26 — — US disclosed
US-3995052-A Indenopyran- and indenothiopyranalkylamines III in the treatment of depression AYERST MCKENNA AND HARRISON LTD. (CA) 1976-11-30 — — US disclosed
US-3983288-A Fibers and fabrics containing optical brightening agents EASTMAN KODAK COMPANY (US) 1976-09-28 — — US disclosed
US-3969527-A INDENO(1,2-C)PYRAZOLE E. R. SQUIBB & SONS, INC. (US) 1976-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160113889-A1 Small Molecule Inhibitors of Dusp6 and Uses Therefor DUSP26, DUSP6, DUSP2 MAOB 4129/4885MIF 161/4885MAOA 4194/4885
US-20040047820-A1 Synergistically high SPF photoprotective UV-screening compositions comprising insoluble organic sunscreen particles/diarylbutadiene compounds SUCLG1, CUTA, DLD MAOB 1776/4885MIF 3072/4885MAOA 2132/4885
US-20160355459-A1 Small Molecule Inhibitors of Dusp6 and Uses Therefor DUSP26, DUSP6, DUSP2 MAOB 4129/4885MIF 161/4885MAOA 4194/4885
US-20030152532-A1 SYNERGISTICALLY UV-PHOTOPROTECTING COMPOSITIONS COMPRISING MIXED SCREENING AGENTS HADHB, SDHA, ERCC4 MAOB 1274/4885MIF 2357/4885MAOA 1696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback